About Propagenix
Propagenix is a company based in Gaithersburg (United States) founded in 2014 was acquired by Stem Cell Technologies in January 2024.. Propagenix has raised $8.8 million across 6 funding rounds from investors including Stem Cell Technologies, HHS and Maryland Stem Cell Research Fund. Propagenix operates in a competitive market with competitors including Enlivex Pharmaceuticals, Orgenesis, Sernova, TissueGene and LyGenesis, among others.
- Headquarter Gaithersburg, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.8 M (USD)
in 6 rounds
-
Latest Funding Round
$182.85 K (USD), Grant
Jan 15, 2021
-
Investors
Stem Cell Technologies
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Stem Cell Technologies
(Jan 19, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Propagenix
Propagenix has successfully raised a total of $8.8M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $182.85 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $182,845
-
First Round
First Round
(22 Apr 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Grant - Propagenix | Valuation |
investors |
|
| Sep, 2018 | Amount | Grant - Propagenix | Valuation |
investors |
|
| May, 2017 | Amount | Grant - Propagenix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Propagenix
Propagenix has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Stem Cell Technologies, HHS and Maryland Stem Cell Research Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stem cell research startups in healthcare are funded and accelerated.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Developer of cell culture media and ancillary reagents for life science research
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Propagenix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Propagenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Propagenix Comparisons
Competitors of Propagenix
Propagenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enlivex Pharmaceuticals, Orgenesis, Sernova, TissueGene and LyGenesis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Autologous and allogeneic cell immunotherapies are developed for autoimmune conditions.
|
|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple disorders are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine to deliver proteins and hormones for disease treatment
|
|
| domain | founded_year | HQ Location |
Regenerative cell therapies for orthopedic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicines for liver disorders are developed using lymph nodes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Propagenix
Frequently Asked Questions about Propagenix
When was Propagenix founded?
Propagenix was founded in 2014.
Where is Propagenix located?
Propagenix is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Is Propagenix a funded company?
Propagenix is a funded company, having raised a total of $8.8M across 6 funding rounds to date.
What does Propagenix do?
Propagenix is an RD-stage cell therapy company engaged in the development of the primary cells, tumor cell models and cell therapies. It is currently focussed on continuing the development of Conditional Replication (CR) technology that generates unlimited quantities of biologically important cell types ex vivo that retain the ability to re-adopt the relevant functionality of the tissues from which the cells originated. It has developed multiple human and other mammalian cell cultures and stable cell lines from tumor cells. Besides, it has a set of cell therapy preclinical-stage programs related to pancreatic diseases, autologous skin engraftment and airway injury and respiratory diseases.
Who are the top competitors of Propagenix?
Propagenix's top competitors include Enlivex Pharmaceuticals, Sernova and Emmaus Medical.
Who are Propagenix's investors?
Propagenix has 3 investors. Key investors include Stem Cell Technologies, HHS, and Maryland Stem Cell Research Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.